The 7 analysts offering 12-month price forecasts for Ginkgo Bioworks Holdings Inc have a median target of 4.00, with a high estimate of 12.00 and a low estimate of 3.00. The median estimate represents a +101.01% increase from the last price of 1.99.
The current consensus among 8 polled investment analysts is to Buy stock in Ginkgo Bioworks Holdings Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.23
Reporting Date Mar 27
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.